Evidence map›Paper›PMID 19805305›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors.

Robert Schlaberg, Daniel J Choe, Kristy R Brown, Harshwardhan M Thaker, Ila R Singh

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 162 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed, 1 pooled it
25.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 1 synthesis or guideline pooled it, 274 citations in OpenAlex.

  1. Pooled it
  2. Male circumcision and prostate cancer: A geographical analysis, meta-analysis, and cost analysis.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2020
    Review
  3. Epidemiology of Prostate Cancer.World journal of oncology · 2019
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Epidemiology of cancers of infectious origin and prevention strategies.Journal of preventive medicine and hygiene · 2015
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Virome genomics: a tool for defining the human virome.Current opinion in microbiology · 2013
    Review
  17. Article
  18. No detection of the retrovirus xenotropic murine leukemia virus-related virus in individuals with hemophilia.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2013
    Article
  19. Article
  20. Article

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Robert SchlabergDepartment of Pathology and Cell Biology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USA.
Daniel J Choe
Kristy R Brown
Harshwardhan M Thaker
Ila R Singh
University of Utah · USColumbia University Irving Medical Center · US

Funding

The role of XMRV, a newly discovered human retrovirus, in cancer pathogenesisR01CA149719 · NCI · UNIVERSITY OF UTAH · PI SINGH, ILA R · 2010 to 2014
$1.5M
NCI NIH HHS R01 CA149719
6 · The paper itself

Abstract

Xenotropic murine leukemia virus-related virus (XMRV) was recently discovered in human prostate cancers and is the first gammaretrovirus known to infect humans. While gammaretroviruses have well-characterized oncogenic effects in animals, they have not been shown to cause human cancers. We provide experimental evidence that XMRV is indeed a gammaretrovirus with protein composition and particle ultrastructure highly similar to Moloney murine leukemia virus (MoMLV), another gammaretrovirus. We analyzed 334 consecutive prostate resection specimens, using a quantitative PCR assay and immunohistochemistry (IHC) with an anti-XMRV specific antiserum. We found XMRV DNA in 6% and XMRV protein expression in 23% of prostate cancers. XMRV proteins were expressed primarily in malignant epithelial cells, suggesting that retroviral infection may be directly linked to tumorigenesis. XMRV infection was associated with prostate cancer, especially higher-grade cancers. We found XMRV infection to be independent of a common polymorphism in the RNASEL gene, unlike results previously reported. This finding increases the population at risk for XMRV infection from only those homozygous for the RNASEL variant to all individuals. Our observations provide evidence for an association of XMRV with malignant cells and with more aggressive tumors.

Indexed as

AdultAgedBase SequenceBlotting, WesternDNA, ViralEndoribonucleasesEpitheliumGammaretrovirusGenotypeHost-Pathogen InteractionsHumansImmunohistochemistryMaleMicroscopy, Electron, TransmissionMiddle AgedMolecular Sequence Data2-5A-dependent ribonucleaseDNA, ViralEndoribonucleasesViral Proteins

Identifiers

PMID19805305
PMCPMC2739868
OpenAlexW2136693006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.